Global Subcutaneous Drug Delivery Devices Market Growth 2024-2030

Publication ID:

LPI03240712

Publication Date:

March 29, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Subcutaneous Drug Delivery Devices market size was valued at US$ million in 2023. With growing demand in downstream market, the Subcutaneous Drug Delivery Devices is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Subcutaneous Drug Delivery Devices market. Subcutaneous Drug Delivery Devices are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Subcutaneous Drug Delivery Devices. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Subcutaneous Drug Delivery Devices market.
A subcutaneous drug delivery device having a housing having an internal reservoir in communication with a drug delivery needle via a fluid path. An expandable chamber disposed adjacent to the reservoir forces drug from the reservoir to the needle when supplied with a gas.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Subcutaneous Drug Delivery Devices market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Subcutaneous Drug Delivery Devices market. It may include historical data, market segmentation by Type (e.g., Prefilled Injectable, Filled Injectable), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Subcutaneous Drug Delivery Devices market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Subcutaneous Drug Delivery Devices market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Subcutaneous Drug Delivery Devices industry. This include advancements in Subcutaneous Drug Delivery Devices technology, Subcutaneous Drug Delivery Devices new entrants, Subcutaneous Drug Delivery Devices new investment, and other innovations that are shaping the future of Subcutaneous Drug Delivery Devices.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Subcutaneous Drug Delivery Devices market. It includes factors influencing customer ' purchasing decisions, preferences for Subcutaneous Drug Delivery Devices product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Subcutaneous Drug Delivery Devices market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Subcutaneous Drug Delivery Devices market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Subcutaneous Drug Delivery Devices market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Subcutaneous Drug Delivery Devices industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Subcutaneous Drug Delivery Devices market.
Market Segmentation:
Subcutaneous Drug Delivery Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Prefilled Injectable
Filled Injectable
Segmentation by application
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BD
Insulet Corporation
Enable Injections
West Pharmaceutical Services, Inc
Ypsomed AG
Elcam Medical
Amgen
Wilhelm Haselmeier
Key Questions Addressed in this Report
What is the 10-year outlook for the global Subcutaneous Drug Delivery Devices market?
What factors are driving Subcutaneous Drug Delivery Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Subcutaneous Drug Delivery Devices market opportunities vary by end market size?
How does Subcutaneous Drug Delivery Devices break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Subcutaneous Drug Delivery Devices Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Subcutaneous Drug Delivery Devices by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Subcutaneous Drug Delivery Devices by Country/Region, 2019, 2023 & 2030
2.2 Subcutaneous Drug Delivery Devices Segment by Type
2.2.1 Prefilled Injectable
2.2.2 Filled Injectable
2.3 Subcutaneous Drug Delivery Devices Sales by Type
2.3.1 Global Subcutaneous Drug Delivery Devices Sales Market Share by Type (2019-2024)
2.3.2 Global Subcutaneous Drug Delivery Devices Revenue and Market Share by Type (2019-2024)
2.3.3 Global Subcutaneous Drug Delivery Devices Sale Price by Type (2019-2024)
2.4 Subcutaneous Drug Delivery Devices Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Subcutaneous Drug Delivery Devices Sales by Application
2.5.1 Global Subcutaneous Drug Delivery Devices Sale Market Share by Application (2019-2024)
2.5.2 Global Subcutaneous Drug Delivery Devices Revenue and Market Share by Application (2019-2024)
2.5.3 Global Subcutaneous Drug Delivery Devices Sale Price by Application (2019-2024)
3 Global Subcutaneous Drug Delivery Devices by Company
3.1 Global Subcutaneous Drug Delivery Devices Breakdown Data by Company
3.1.1 Global Subcutaneous Drug Delivery Devices Annual Sales by Company (2019-2024)
3.1.2 Global Subcutaneous Drug Delivery Devices Sales Market Share by Company (2019-2024)
3.2 Global Subcutaneous Drug Delivery Devices Annual Revenue by Company (2019-2024)
3.2.1 Global Subcutaneous Drug Delivery Devices Revenue by Company (2019-2024)
3.2.2 Global Subcutaneous Drug Delivery Devices Revenue Market Share by Company (2019-2024)
3.3 Global Subcutaneous Drug Delivery Devices Sale Price by Company
3.4 Key Manufacturers Subcutaneous Drug Delivery Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Subcutaneous Drug Delivery Devices Product Location Distribution
3.4.2 Players Subcutaneous Drug Delivery Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Subcutaneous Drug Delivery Devices by Geographic Region
4.1 World Historic Subcutaneous Drug Delivery Devices Market Size by Geographic Region (2019-2024)
4.1.1 Global Subcutaneous Drug Delivery Devices Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Subcutaneous Drug Delivery Devices Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Subcutaneous Drug Delivery Devices Market Size by Country/Region (2019-2024)
4.2.1 Global Subcutaneous Drug Delivery Devices Annual Sales by Country/Region (2019-2024)
4.2.2 Global Subcutaneous Drug Delivery Devices Annual Revenue by Country/Region (2019-2024)
4.3 Americas Subcutaneous Drug Delivery Devices Sales Growth
4.4 APAC Subcutaneous Drug Delivery Devices Sales Growth
4.5 Europe Subcutaneous Drug Delivery Devices Sales Growth
4.6 Middle East & Africa Subcutaneous Drug Delivery Devices Sales Growth
5 Americas
5.1 Americas Subcutaneous Drug Delivery Devices Sales by Country
5.1.1 Americas Subcutaneous Drug Delivery Devices Sales by Country (2019-2024)
5.1.2 Americas Subcutaneous Drug Delivery Devices Revenue by Country (2019-2024)
5.2 Americas Subcutaneous Drug Delivery Devices Sales by Type
5.3 Americas Subcutaneous Drug Delivery Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Subcutaneous Drug Delivery Devices Sales by Region
6.1.1 APAC Subcutaneous Drug Delivery Devices Sales by Region (2019-2024)
6.1.2 APAC Subcutaneous Drug Delivery Devices Revenue by Region (2019-2024)
6.2 APAC Subcutaneous Drug Delivery Devices Sales by Type
6.3 APAC Subcutaneous Drug Delivery Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Subcutaneous Drug Delivery Devices by Country
7.1.1 Europe Subcutaneous Drug Delivery Devices Sales by Country (2019-2024)
7.1.2 Europe Subcutaneous Drug Delivery Devices Revenue by Country (2019-2024)
7.2 Europe Subcutaneous Drug Delivery Devices Sales by Type
7.3 Europe Subcutaneous Drug Delivery Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Subcutaneous Drug Delivery Devices by Country
8.1.1 Middle East & Africa Subcutaneous Drug Delivery Devices Sales by Country (2019-2024)
8.1.2 Middle East & Africa Subcutaneous Drug Delivery Devices Revenue by Country (2019-2024)
8.2 Middle East & Africa Subcutaneous Drug Delivery Devices Sales by Type
8.3 Middle East & Africa Subcutaneous Drug Delivery Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Subcutaneous Drug Delivery Devices
10.3 Manufacturing Process Analysis of Subcutaneous Drug Delivery Devices
10.4 Industry Chain Structure of Subcutaneous Drug Delivery Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Subcutaneous Drug Delivery Devices Distributors
11.3 Subcutaneous Drug Delivery Devices Customer
12 World Forecast Review for Subcutaneous Drug Delivery Devices by Geographic Region
12.1 Global Subcutaneous Drug Delivery Devices Market Size Forecast by Region
12.1.1 Global Subcutaneous Drug Delivery Devices Forecast by Region (2025-2030)
12.1.2 Global Subcutaneous Drug Delivery Devices Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Subcutaneous Drug Delivery Devices Forecast by Type
12.7 Global Subcutaneous Drug Delivery Devices Forecast by Application
13 Key Players Analysis
13.1 BD
13.1.1 BD Company Information
13.1.2 BD Subcutaneous Drug Delivery Devices Product Portfolios and Specifications
13.1.3 BD Subcutaneous Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 BD Main Business Overview
13.1.5 BD Latest Developments
13.2 Insulet Corporation
13.2.1 Insulet Corporation Company Information
13.2.2 Insulet Corporation Subcutaneous Drug Delivery Devices Product Portfolios and Specifications
13.2.3 Insulet Corporation Subcutaneous Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Insulet Corporation Main Business Overview
13.2.5 Insulet Corporation Latest Developments
13.3 Enable Injections
13.3.1 Enable Injections Company Information
13.3.2 Enable Injections Subcutaneous Drug Delivery Devices Product Portfolios and Specifications
13.3.3 Enable Injections Subcutaneous Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Enable Injections Main Business Overview
13.3.5 Enable Injections Latest Developments
13.4 West Pharmaceutical Services, Inc
13.4.1 West Pharmaceutical Services, Inc Company Information
13.4.2 West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Product Portfolios and Specifications
13.4.3 West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 West Pharmaceutical Services, Inc Main Business Overview
13.4.5 West Pharmaceutical Services, Inc Latest Developments
13.5 Ypsomed AG
13.5.1 Ypsomed AG Company Information
13.5.2 Ypsomed AG Subcutaneous Drug Delivery Devices Product Portfolios and Specifications
13.5.3 Ypsomed AG Subcutaneous Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Ypsomed AG Main Business Overview
13.5.5 Ypsomed AG Latest Developments
13.6 Elcam Medical
13.6.1 Elcam Medical Company Information
13.6.2 Elcam Medical Subcutaneous Drug Delivery Devices Product Portfolios and Specifications
13.6.3 Elcam Medical Subcutaneous Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Elcam Medical Main Business Overview
13.6.5 Elcam Medical Latest Developments
13.7 Amgen
13.7.1 Amgen Company Information
13.7.2 Amgen Subcutaneous Drug Delivery Devices Product Portfolios and Specifications
13.7.3 Amgen Subcutaneous Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Amgen Main Business Overview
13.7.5 Amgen Latest Developments
13.8 Wilhelm Haselmeier
13.8.1 Wilhelm Haselmeier Company Information
13.8.2 Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Product Portfolios and Specifications
13.8.3 Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Wilhelm Haselmeier Main Business Overview
13.8.5 Wilhelm Haselmeier Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂